These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34845313)

  • 1. The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial.
    El Borolossy R; El-Farsy MS
    Eur J Clin Nutr; 2022 Jun; 76(6):848-854. PubMed ID: 34845313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
    Oikonomaki T; Papasotiriou M; Ntrinias T; Kalogeropoulou C; Zabakis P; Kalavrizioti D; Papadakis I; Goumenos DS; Papachristou E
    Int Urol Nephrol; 2019 Nov; 51(11):2037-2044. PubMed ID: 31529295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
    Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
    Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
    Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
    Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Pol Arch Med Wewn; 2015; 125(9):631-40. PubMed ID: 26176325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
    Aoun M; Makki M; Azar H; Matta H; Chelala DN
    BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
    Alshahawey M; El Borolossy R; El Wakeel L; Elsaid T; Sabri NA
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):626-633. PubMed ID: 33594986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
    Grzejszczak P; Kurnatowska I
    Kidney Blood Press Res; 2021; 46(5):523-530. PubMed ID: 34247173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
    Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
    J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.
    De Vriese AS; Caluwé R; Pyfferoen L; De Bacquer D; De Boeck K; Delanote J; De Surgeloose D; Van Hoenacker P; Van Vlem B; Verbeke F
    J Am Soc Nephrol; 2020 Jan; 31(1):186-196. PubMed ID: 31704740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.
    Witham MD; Lees JS; White M; Band M; Bell S; Chantler DJ; Ford I; Fulton RL; Kennedy G; Littleford RC; McCrea IV; McGlynn D; Panarelli M; Ralston MR; Rutherford E; Severn A; Thomson N; Traynor JP; Struthers AD; Wetherall K; Mark PB
    J Am Soc Nephrol; 2020 Oct; 31(10):2434-2445. PubMed ID: 32817311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
    Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
    Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-mediated vitamin K and vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy.
    Janus SE; Durieux JC; Hajjari J; Carneiro H; McComsey GA
    AIDS; 2022 Apr; 36(5):647-655. PubMed ID: 34907958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Naito T; Tanji C; Usui K; Doi S; Masaki T; Shigemoto K
    Ren Fail; 2019 Nov; 41(1):770-777. PubMed ID: 31538831
    [No Abstract]   [Full Text] [Related]  

  • 16. Combining phosphate binder therapy with vitamin K2 inhibits vascular calcification in an experimental animal model of kidney failure.
    Neradova A; Wasilewski G; Prisco S; Leenders P; Caron M; Welting T; van Rietbergen B; Kramann R; Floege J; Vervloet MG; Schurgers LJ
    Nephrol Dial Transplant; 2022 Mar; 37(4):652-662. PubMed ID: 34718756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial.
    Naiyarakseree N; Phannajit J; Naiyarakseree W; Mahatanan N; Asavapujanamanee P; Lekhyananda S; Vanichakarn S; Avihingsanon Y; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vitamin K in vascular calcification of patients with chronic kidney disease.
    Wuyts J; Dhondt A
    Acta Clin Belg; 2016 Dec; 71(6):462-467. PubMed ID: 27254816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
    Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK).
    Haroon S; Davenport A; Ling LH; Tai BC; Teo LL; Schurgers L; Chen Z; Shroff R; Fischer DC; Khatri P; Low S; Tan JN; Chua HR; Teo BW; Ong CC; Subramanian S; Yeo XE; Wong WK; Lau TW
    Kidney Int Rep; 2023 Sep; 8(9):1741-1751. PubMed ID: 37705910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.